Benzinga | Oct 26, 2021 07:14AM EDT

Cantor Fitzgerald Assumes 89bio at Overweight, Price Target of $49

Cantor Fitzgerald analyst Kristen Kluska assumes 89bio (NASDAQ:ETNB) with a Overweight rating and lowers Price Target to $49.